Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience2006Xu K, Xu Y, Brown-Jermyn D, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2006
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

3,4-Dihydroxyphenylacetic AcidAge FactorsAnimalsCaffeineCorpus StriatumCytochrome P-450 CYP1A2DopamineDrug ImplantsEstradiolEstrogen Replacement TherapyFemaleMaleMethylationMiceMice, Inbred C57BLNeuroprotective AgentsOvariectomyParkinsonian DisordersSex Characteristics

DOI 10.1523/jneurosci.3008-05.2006

PMID 16407551

View source →